Secondly, dihydroartemisinin improves the immunosuppressive TME-induced immune escape by inhibiting YAP1, which leads to decreased PD-L1 expression in liver tumor cells and increased tumor-infiltrating CD8+T cells (36). The gene discussed is CD274; the disease is neoplasm.